Seqirus opens U.K. office; Mitsubishi Tanabe plans U.S. flu vaccine;

> CSL's flu vaccine unit Seqirus opened a U.K. corporate office. Release

> Japan's Mitsubishi Tanabe Pharma plans to focus on increasing its U.S. sales, with one component of its strategy involving a flu vaccine currently under development. Report

> A paper in PLOS Medicine argues in favor of a compensation system for vaccine injuries for cases such as the Ebola outbreak in which vaccines must be tested rapidly without hesitation due to liability. More